Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment. - Silverman,D.H.; Cummings,J.L.; Small,G.W. (Mol Imaging Biol, 2002)